mTORC1 Inhibition Is an Effective Treatment for Sporadic Renal Angiomyolipoma
2017 · Kidney International Reports · 13 citations
https://doi.org/10.1016/j.ekir.2017.07.016
D
Dorit Omer
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
29
Papers
850
Citations
14
h-index
17
i10-index
Dorit Omer is an academic researcher from Tel Aviv University. The author has contributed to research in topics: Renal and related cancers & Renal cell carcinoma treatment & Pluripotent Stem Cells Research. The author has an h-index of 14, co-authored 25 publications.
Papers by this author
worksHuman fetal kidney organoids model early human nephrogenesis and Notch-driven cell fate
2025 · The EMBO Journal · 3 citations
https://doi.org/10.1038/s44318-025-00504-2
Optical genome and epigenome mapping of clear cell renal cell carcinoma
2025 · NAR Cancer · 0 citations
https://doi.org/10.1093/narcan/zcaf008
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat